Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment

BACKGROUND: Despite its recognised toxicity, antimonial therapy continues to be the first-line drug for cutaneous leishmaniasis (CL) treatment. Intralesional administration of meglumine antimoniate (MA) represents an alternative that could reduce the systemic absorption of the drug and its side effe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mem Inst Oswaldo Cruz
Päätekijät: da Silva, Rosiana Estéfane, Carvalho, Janaína de Pina, Ramalho, Dario Brock, Senna, Maria Camilo Ribeiro De, Moreira, Hugo Silva Assis, Rabello, Ana, Cota, Erika, Cota, Gláucia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Instituto Oswaldo Cruz, Ministério da Saúde 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722261/
https://ncbi.nlm.nih.gov/pubmed/29236929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-027601700125
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia